News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...


Recent Postings


Archive


Tags

NANTKWEST (NK) Ridaforolimus Theravance (THRX) Rapamune Alnylam (ALNY) Trastuzumab-DM1 OSI (OSIP) Inovio (INO) Pluristem (PSTI) Auspex (ASPX) JUNO (JUNO) Mirati Therapeutics (MRTX) Sequenom (SQNM) Incyte (INCY) Herceptin Seattle Genetics (SGEN) IDERA (IDRA) Idenix (IDIX) Roche (ROCHE) ABBVIE (ABBV) Anadys (ANDS) NEKTAR (NKTR)) Array Pharmaceuticals (ARRY) KERYX (KERX) TOKAI (TKAOI) Revlimid (lenolidamide) Prosensa (RNA) Elan (ELN) Exelixis (EXEL) SYNTA (SNTA) Amgen (AMGN) ARCA (ABIO) Sanofi (SNA) ISIS (ISIS) Genentech Merck (MRK) Dynavax (DVAX) Valeant Pharmaceuticals International (VRX) Telaprevir Velcade (bortezomib) ADVENTRIX (ANX) Aimmune Therapeutics (AIMT) Bristol-Myers Squibb (BMY) Agenus (AGEN) Human Genome Sciences (HGSI) HALOZYME (HALO) Agenus (AGEN Cytokinetics (CYTK) Anacor (ANAC) Illumina (ILMN) GUARDIAN HEALTH Jazz Pharmaceuticals (JAZZ) C4 Therapeutics Sangamo (SGMO) Biocryst (BCRX) Vertex (VRTX) Ziofpharm (ZIOP) Xoma (XOMA) GlaxoSmithKline (GSK) Roche (RHHBY) Benlysta (belimumab) Prolor Biotech (PBTH) AERIE PHARMACEUTICALS Zerenex BIOMARIN (BMRN) Multiple Myeloma Regeneron (REGN) ZALTRAP™ Galena (GALE) Dendreon (DNDN) Biogen Idec (BIIB) Sarepta (SRPT) Gilead (GILD) Micromet (MITI) SERES THERAPEUTICS (MCRB) Intrexon (XON) VANDA (VNDA) ImmunoGen (IMGN) Ariad (ARIA) Onyx (ONXX) KITE (KITE) Intermune (ITMN) SUNESIS PHARMACEUTICALS (SNSS) CompuGen (CGEN) Sanofi (SNY) Intercept (ICPT) Abbott Laboratories (ABT) Endometrial Cancer Sanofi-Aventis (SAN) galapagos (GLPG) Tysabri